CliffBio
small molecule

DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameDONEPEZIL HYDROCHLORIDE
Active ingredientDONEPEZIL HYDROCHLORIDE
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.